Dr Christopher Hillyar

Dr Christopher Hillyar is a Teaching Associate at Green Templeton College, University of Oxford.

Dr Christopher Hillyar, MBBS (Lond) BSc MSc (Oxon) DPhil (Oxon) PGCert MAcadMEd FRSPH, is a Teaching Associate for the Graduate-Entry Medicine programme, where he delivers case-based teaching across the entire year-one syllabus and assists with delivering and assessing formative and summative OSCEs for final-year clinical medicine students.

Christopher holds a PGCert in Health Professions Education from the University of York, and concurrently delivers the Evidence-Based Practice module for the Advanced Clinical Practice masters programme as Associate Lecturer at BNU. Christopher completed the Graduate-Entry Medicine (MBBS) programme at Barts and The London School of Medicine and Dentistry, where he obtained a double distinction.

Before studying medicine, Christopher trained in Biomedical Science, graduating top of his year with first class honours from Durham University. His first undergraduate was followed by an MRC-funded 4-year MSc/DPhil in radiobiology supervised by Prof Katherine Vallis and Prof Bart Cornelissen at the Oxford Institute of Radiation Biology, Department of Oncology, University of Oxford. His DPhil thesis characterised the anticancer effects of a nucleolin-targeting peptide-based radiopharmaceutical labelled with the Auger electron-emitting radionuclide, 111-Indium. This work was the first to utilise Monte Carlo modelling to calculate radiation dose deposited by a radiopharmaceutical in the nucleoli of individual cancer cells.

Christopher has published 18 peer-reviewed articles, presented research at 24 national and international conferences, and secured over £85,000 in grants, scholarships and prize awards. He is Principle Investigator for the Academic Match programme at Green Templeton.

Currently, he supervises three clinical medicine students conducting research projects on the impact of total intravenous anaesthesia (propofol infusion) or inhalational anaesthesia (volatile gases) on disease pathophysiology, intra-operative factors and short-term and long-term post-operative outcomes for different types of surgery (e.g. oncological surgery). Christopher is a member of several editorial boards at Frontiers, where he plays an active role in shaping the academic direction of Frontiers in Medicine, Frontiers in Cell and Developmental Biology, and Frontiers in Genetics.

In his NHS training, Christopher is currently rotating through Emergency Medicine, Acute Medicine, Intensive Care Medicine and Anaesthetics as part of the Acute Care Common Stem (ACCS) training programme. He holds a National Training Number in Anaesthetics and has worked at the John Radcliffe, Churchill, Royal Berkshire and Stoke Mandeville Hospitals.

In his spare time, Christopher enjoys travelling, walking and running. He and his wife, Anjan, are looking forward to welcoming their first child in June 2024.